Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (1): 70-74.doi: 10.6040/j.issn.1673-3770.0.2021.117

Previous Articles     Next Articles

Short-term effect of Dermatophagoides farinae specific sublingual immunotherapy for children with allergic rhinitis

PANG Chong1, BIAN Sainan2,3,4, ZHANG Bing1, YIN Xu1, LU Yingxia1, YE Pengfei1, WANG Zhan1, ZHAO Jing1, GAO Yan1, GUAN Kai2,3,4   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, Capital Institute of Pediatrics affiliated Children's Hospital, Beijing, 100730, China;
    2. Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China;
    3. Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment of Allergic Disease, Beijing, 100730, China;
    4. National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
  • Published:2022-02-22

PDF (PC)

629

Abstract: Objective To evaluate the short-term effect of Dermatophagoides farinae specific sublingual immunotherapy for children with allergic rhinitis. Methods Children attended in the department of otorhinolaryngology head and neck surgery, Capital Institute of Pediatrics affiliated Children's Hospital and received Dermatophagoides farinae specific sublingual immunotherapy for 6 months were enrolled from 2019 to 2020. Visual analogue scale(VAS), total nasal symptoms score(TNSS), total medication score(TMS), and combined symptom and medication score(CSMS)before and after immunotherapy were collected. Results In total 50 children with allergic rhinitis were enrolled, with an average age of(7.7±2.7)years old. Before immunotherapy, VAS, TNSS, TMS and CSMS was(5.5±1.6)score,(5.5±2.2)score,(3.0±0.1)score,(4.3±0.6)score, respectively. And after immunotherapy for 6 months, VAS, TNSS, TMS and CSMS was(2.5±1.4)score,(2.2±1.6)score,(0.6±1.1)score,(1.2±1.2)score, respectively. The scores were all decreased significantly after immunotherapy(P<0.05). Conclusion Short term efficacy of Dermatophagoides farinae specific sublingual immunotherapy is good for children with allergic rhinitis.

Key words: Allergic rhinitis, Dermatophagoides farinae, Sublingual immunotherapy

CLC Number: 

  • R765
[1] Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis. Lancet[J] , 2011,378(9809):2112-2122. doi: 10.1016/S0140-6736(11)60130-X.
[2] Schuler Iv CF, Montejo JM. Allergic rhinitis in children and adolescents[J]. Pediatr Clin N Am, 2019, 66(5): 981-993. doi:10.1016/j.pcl.2019.06.004.
[3] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(1 Suppl): S1-S43. doi:10.1177/0194599814561600.
[4] Pfaar O, Agache I, de Blay F, et al. Perspectives in allergen immunotherapy: 2019 and beyond[J]. Allergy, 2019, 74(Suppl 108): 3-25. doi:10.1111/all.14077.
[5] Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis[J]. Allergy, 2018, 73(4): 765-798. doi:10.1111/all.13317.
[6] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015, 136(3): 556-568. doi:10.1016/j.jaci.2015.04.047.
[7] Wheatley LM, Togias A. Clinical practice. Allergic rhinitis[J]. N Engl J Med, 2015, 372(5): 456-463. doi: 10.1056/NEJMcp1412282.
[8] Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: Prevention of allergy[J]. Pediatr Allergy Immunol, 2017, 28(8): 728-745. doi:10.1111/pai.12807.
[9] Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? [J]. J Allergy Clin Immunol, 2016, 137(2): 339-349.e10. doi:10.1016/j.jaci.2015.12.1298.
[10] Vita D, Caminiti L, Ruggeri P, et al. Sublingual immunotherapy: adherence based on timing and monitoring control visits[J]. Allergy, 2010, 65(5): 668-669. doi:10.1111/j.1398-9995.2009.02223.x.
[11] Vogelberg C, Brüggenjürgen B, Richter H, et al. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma[J]. Patient Prefer Adherence, 2020, 14: 817-827. doi:10.2147/PPA.S242957.
[12] Manzotti G, Riario-Sforza GG, Dimatteo M, et al. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment[J]. Eur Ann Allergy Clin Immunol, 2016, 48(6): 224-227.
[13] 刘湘, 楼响瑜, 高月秋, 等. 变应性鼻炎患者变应原谱及舌下免疫治疗分析[J]. 中国耳鼻咽喉头颈外科, 2019, 26(9): 491-494. doi:10.16066/j.1672-7002.2019.09.007. LIU Xiang, LOU Xiangyu, GAO Yueqiu, et al. Allergen spectrum and sublingual specific immunotherapy analysis in allergic thinitis patients[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2019, 26(9): 491-494. doi:10.16066/j.1672-7002.2019.09.007.
[14] Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis[J]. Cochrane Database Syst Rev, 2003(2): CD002893. doi:10.1002/14651858.cd002893.
[15] Nolte H, Bernstein DI, Nelson HS, et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial[J]. J Allergy Clin Immunol, 2016, 138(6): 1631-1638. doi:10.1016/j.jaci.2016.06.044.
[16] Demoly P, Emminger W, Rehm D, et al. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial[J]. J Allergy Clin Immunol, 2016, 137(2): 444-451.e8. doi:10.1016/j.jaci.2015.06.036.
[17] Okubo K, Masuyama K, Imai T, et al. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis[J]. J Allergy Clin Immunol, 2017, 139(6): 1840-1848.e10. doi:10.1016/j.jaci.2016.09.043.
[18] Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis[J]. Allergy, 2017, 72(11): 1597-1631. doi:10.1111/all.13201.
[19] Hoseini RF, Jabbari F, Rezaee A, et al. House dust mite sublingual-swallow immunotherapy in perennial rhinitis: a double-blind, placebo-controlled Iranian study[J]. J Biol Regul Homeost Agents, 2018, 32(1): 83-88.
[20] 王丰, 张虹婷, 孟娟. 皮下免疫与舌下免疫治疗变应性鼻炎的疗效比较[J]. 重庆医学, 2017, 46(21): 2906-2908. doi:10.3969/j.issn.1671-8348.2017.21.008. WANG Feng, ZHANG Hongting, MENG Juan. Comparison of efficacy of subcutaneous immunotherapy and sublingual immunotherapy for treating allergic rhinitis[J]. Chongqing Medicine, 2017, 46(21): 2906-2908. doi:10.3969/j.issn.1671-8348.2017.21.008.
[21] Bergmann KC, Demoly P, Worm M, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis[J]. J Allergy Clin Immunol, 2014, 133(6): 1608-1614.e6. doi:10.1016/j.jaci.2013.11.012.
[22] Mosbech H, Canonica GW, Backer V, et al. SQ house dust mite sublingually administered immunotherapy tablet(ALK)improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms[J]. Ann Allergy Asthma Immunol, 2015, 114(2): 134-140. doi:10.1016/j.anai.2014.11.015.
[23] Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update[J]. World Allergy Organ J, 2014, 7(1): 6. doi:10.1186/1939-4551-7-6.
[24] Calderon MA, Casale TB, Nelson HS, et al. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies[J]. J Allergy Clin Immunol, 2013, 132(6): 1322-1336. doi:10.1016/j.jaci.2013.09.004.
[25] de Bot CM, Moed H, Berger MY, et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care[J]. Pediatr Allergy Immunol, 2012, 23(2): 150-158. doi:10.1111/j.1399-3038.2011.01219.x.
[1] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[2] GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111.
[3] QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[7] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[8] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[9] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[10] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[11] LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58.
[12] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
[13] WANG Manxian, ZHENG Quan, YANG Liang. Research progress in the treatment of allergic rhinitis with bacterial lysates [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 141-145.
[14] LIU Chang, FANG Hongyan, LIU Xiao, FU Dongna, WANG He, WANG Jing, YANG Jingpu. Analysis of sensitization characteristics of Artemisia pollen in autumn allergic rhinitis in the Changchun area of China [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 13-19.
[15] ZHANG Jie, CHEN Min, SHEN Zhengzheng, WU Yuhua, LIU Yuanhu, SUN Hao, TAN Xinhua, NI Shuren, YANG Shuxun, SHI Xuezheng, NI Xin. Study on the correlation between allergic rhinitis and coronavirus disease-2019 infection and symptoms in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 36-42.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd